Figure 6.
The best poses in the molecular docking of DTIs. (A) FGFR1 and CHEMBL328029. (B) ALK and CHEMBL1165499. (C) AKT1 and CHEMBL1773601. (D) AKT1 and CHEMBL1773581. (E) FLT3 and CHEMBL388978. (F) PIK3CA and CHEMBL1615189. (G) FGRF1 and levatinib. (H) PIK3CA and regorafenib. (I) PIK3CA and sorafenib. Blue dotted lines for hydrogen bonds, yellow for electrostatic interactions, and grey for hydrophobic interactions allow to observe how our drug compounds interact with target proteins.